Personalizing radiation therapy for cancer treatment using patient-specific factors.
Integrating patient-specific clinical and biological factors towards individualizing utilization of proton and photon radiation therapy.
This study is looking at how to make cancer treatment better by personalizing radiation therapy for each patient, so you can get a treatment plan that works best for you and has fewer side effects.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10929957 on NIH RePORTER |
What this research studies
This research focuses on improving cancer treatment by integrating individual clinical and biological factors to tailor the use of proton and photon radiation therapies. By analyzing how different patients respond to these therapies, the project aims to enhance treatment effectiveness and minimize side effects. The approach includes conducting randomized trials and developing advanced treatment techniques that account for variations in patient characteristics. Patients may benefit from a more personalized treatment plan that is better suited to their unique biological makeup.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients who are being considered for radiation therapy, particularly those with esophageal, liver, or glioma cancers.
Not a fit: Patients who do not have cancer or those whose treatment does not involve radiation therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized radiation therapy options for cancer patients.
How similar studies have performed: Previous research has shown promise in using personalized approaches to radiation therapy, indicating that this method could lead to significant advancements in cancer treatment.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Hong, Theodore S — Massachusetts General Hospital
- Study coordinator: Hong, Theodore S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.